Subsidiary gets land conversion order for 300-room Udaipur luxury resort

Business Updates View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.5%Reaction day

₹12.14

prior close

₹12.31

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.9%-1.4% vs market

Other Food Products peers, median of 23sector+0.5%-0.0% vs sector

On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and in line with its Other Food Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.0

10m

+1.9

15m

+2.3

30m

+2.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.5+1.9-1.4+0.5-0.0

Next day

+0.8+3.3-2.5-0.0+0.8

+1.6+3.5-1.8+1.5+0.2

-0.3+2.4-2.8+0.8-1.2

-1.1+3.1-4.2+1.1-2.2

+1.6+2.6-1.0+0.8+0.9

+2.1+2.1+0.0+0.8+1.3

15d

+2.6+0.9+1.7-1.6+4.2

+0.9+5.5-4.6+1.5-0.6

+1.5+8.1-6.6-3.0+4.5

-1.4+3.5-4.9-5.8+4.4

UpDownMarket · Nifty Microcap 250Sector · Other Food Products peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Saboo Sodium Chloro's wholly-owned subsidiary Samskara Resorts received a land conversion order from the Udaipur Development Authority for a 23,310 sq m parcel near Maharana Pratap Airport. The company plans a luxury resort with up to 300 rooms, including restaurants, banqueting, wellness and recreation facilities. Maithel and Associates appointed as project architect. Next steps include building plan approvals and other statutory clearances before construction timelines are finalised.

Likely market impact

Positive regulatory milestone for hospitality diversification, but further approvals and execution risks remain.